SIGA Technologies Inc

NASDAQ SIGA

Data sourced from iex and EODHD
Download Data

SIGA Technologies Inc Stock-Based Compensation for the year ending December 31, 2023: USD 2.05 M

SIGA Technologies Inc Stock-Based Compensation is USD 2.05 M for the year ending December 31, 2023, a 15.35% change year over year. Stock-Based Compensation represents the cost of employee compensation provided in the form of equity-based instruments, such as stock options or restricted stock units.
  • SIGA Technologies Inc Stock-Based Compensation for the year ending December 31, 2022 was USD 1.78 M, a 40.57% change year over year.
  • SIGA Technologies Inc Stock-Based Compensation for the year ending December 31, 2021 was USD 1.27 M, a -6.30% change year over year.
  • SIGA Technologies Inc Stock-Based Compensation for the year ending December 31, 2020 was USD 1.35 M, a -36.09% change year over year.
  • SIGA Technologies Inc Stock-Based Compensation for the year ending December 31, 2019 was USD 2.11 M, a -7.00% change year over year.
NASDAQ: SIGA

SIGA Technologies Inc

CEO Dr. Phillip Louis Gomez III, M.D., Ph.D.
IPO Date Sept. 9, 1997
Location United States
Headquarters 31 East 62nd Street, New York, NY, United States, 10065
Employees 45
Sector Healthcare
Industry Drug manufacturers - specialty & generic
Description

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Similar companies

CTLT

Catalent Inc

NA

NA

PAHC

Phibro Animal Health Corporation

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email